Can we make use of our organoid pipeline to precise treatment selection of NMIBC patients? Excited to conduct the GAIN-INST trial with a great scientific-clinical team @MariannKruithof @AbtDominik @je_bla @martademenna #SpitalzentrumBiel @unibern
rdcu.be/dbW79
rdcu.be/dbW79